| Announce Date | 02/02/2026 |
| EPS Normalized Actual | $1.63 (Beat by $0.06) |
| EPS GAAP Actual | $1.63 (Beat by $0.06) |
| Revenue Actual | $25.981B |
| Revenue Surprise | Beat by $25981M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 10.0849 | 10.78 | 9.55486 | 10.36882 | 4 |
| Sep 2029 | 8.7975 | 12.36 | 8.44702 | 9.09479 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.34 | 1.34 | 25.981B | 4.97% | 25981M |
| FQ3 2025 (Sep 2025) | 0.73 | 0.73 | 22.464B | -0.49% | 22464M |
| FQ2 2025 (Jun 2025) | 2.92 | 2.92 | 23.576B | 2.25% | 23576M |
| FQ1 2025 (Mar 2025) | 1.81 | 1.81 | 23.621B | 6.51% | 23621M |
| FQ4 2024 (Dec 2024) | 1.41 | 1.41 | 24.69B | 4.62% | 24690M |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 22.574B | 1.08% | 22574M |
| FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 23.046B | 5.34% | 23046M |
| FQ1 2024 (Mar 2024) | -0.0109 | -0.0109 | 22.083B | 100% | 22083M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 3.0464 | -- | 2.91677 | 3.16526 | 8 |
| FQ1 2030 (Mar 2030) | 2.9049 | -- | 2.78129 | 3.01824 | 7 |
| FQ4 2029 (Dec 2029) | 2.8036 | -- | 2.7054 | 2.88113 | 4 |
| FQ3 2029 (Sep 2029) | 1.9585 | -- | 1.91784 | 1.98396 | 14 |
| FQ2 2029 (Jun 2029) | 2.4567 | -- | 2.40569 | 2.48864 | 7 |
| FQ1 2029 (Mar 2029) | 2.2055 | -- | 2.15971 | 2.23417 | 7 |
| FQ4 2028 (Dec 2028) | 2.4218 | -- | 2.33697 | 2.48877 | 10 |
| FQ3 2028 (Sep 2028) | 1.9078 | -- | 1.9078 | 1.9078 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 30.67B | -- | 29.67B | 31.59B | 9 |
| FQ1 2030 (Mar 2030) | 30.18B | -- | 29.19B | 31.09B | 8 |
| FQ4 2029 (Dec 2029) | 31.71B | -- | 30.86B | 32.38B | 4 |
| FQ3 2029 (Sep 2029) | 28.48B | -- | 28.02B | 28.76B | 13 |
| FQ2 2029 (Jun 2029) | 28.32B | -- | 27.87B | 28.6B | 7 |
| FQ1 2029 (Mar 2029) | 27.76B | -- | 27.32B | 28.04B | 7 |
| FQ4 2028 (Dec 2028) | 30.27B | -- | 29.46B | 30.92B | 3 |
| FQ3 2028 (Sep 2028) | 25.61B | -- | 25.61B | 25.61B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.34 | 1.34 | 100% | |
| FQ3 2025 (Sep 2025) | 0.73 | 0.73 | 100% | |
| FQ2 2025 (Jun 2025) | 2.92 | 2.92 | 100% | |
| FQ1 2025 (Mar 2025) | 1.81 | 1.81 | 100% | |
| FQ4 2024 (Dec 2024) | 1.41 | 1.41 | 100% | |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 100% | |
| FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0109 | -0.0109 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $25.98B | $25981M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $22.46B | $22464M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $23.58B | $23576M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $23.62B | $23621M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $24.69B | $24690M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $22.57B | $22574M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $23.05B | $23046M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $22.08B | $22083M | 100% |